{"id":2690,"date":"2017-07-06T09:41:32","date_gmt":"2017-07-06T09:41:32","guid":{"rendered":"http:\/\/www.medicalmarijuanainc.com\/?p=25439"},"modified":"2017-07-06T09:41:32","modified_gmt":"2017-07-06T09:41:32","slug":"forbes-bloomberg-global-press-cover-medical-marijuana-inc-subsidiary-hempmeds-mexico-first-office-opening-monterrey-mexico","status":"publish","type":"post","link":"https:\/\/medicalmarijuanainc.com\/2017\/07\/06\/forbes-bloomberg-global-press-cover-medical-marijuana-inc-subsidiary-hempmeds-mexico-first-office-opening-monterrey-mexico\/","title":{"rendered":"Forbes, Bloomberg, Global Press Cover Medical Marijuana, Inc. Subsidiary HempMeds\u00ae Mexico First Office Opening in Monterrey, Mexico"},"content":{"rendered":"

Coverage Also Highlights Company’s Appointment of Renowned Medical Cannabis Advocate and Por Grace Foundation Founder Raul Elizalde as President<\/em><\/h3>\n
\n
\n

SAN DIEGO<\/span>,\u00a0July 6, 2017<\/span>\u00a0—\u00a0Medical Marijuana, Inc.\u00a0(MJNA), the first publicly traded cannabis company in\u00a0the\u00a0United States<\/span>, today announced that its subsidiary\u00a0HempMeds\u00ae Mexico<\/a>\u00a0received international media attention\u00a0during the June 28, 2017 inauguration of HempMeds\u00ae Mexico’s first office<\/a>\u00a0in\u00a0Monterrey, Nuevo Leon, Mexico<\/span>. Coverage also included the Company’s appointment of medical cannabis activist and\u00a0Por Grace Foundation<\/a>\u00a0founder\u00a0Raul Elizalde as President in\u00a0Mexico<\/span>.<\/p>\n<\/div>\n<\/div>\n

\u00a0A Huffington Post article, “Monterrey: de ciudad industrial a meca de la marihuana medicinal<\/a>,” or “Monterrey<\/span>: from industrial city to medical marijuana mecca,” and other news coverage from major international and national\u00a0Mexico<\/span>news outlets discuss the opening of HempMeds\u00ae\u00a0Mexico’s<\/span>\u00a0new office in\u00a0Mexico<\/span>\u00a0and recent medical cannabis reforms that are sweeping the country. Mexico President\u00a0Pena Nieto\u00a0signed a bill into law<\/a>\u00a0June 19<\/span>, 2017\u00a0that officially legalized the cultivation, production, and use of cannabis products with less than 1% THC for medical use in\u00a0Mexico.<\/div>\n
\n
\n

An article from Forbes, “5 retos para la venta de marihuana medicinal en M\u00e9xico<\/a>,” or “5 challenges for the sale of medical marijuana in\u00a0Mexico<\/span>,” discusses HempMeds\u00ae\u00a0Mexico’s<\/span>\u00a0strategy for cannabidiol (CBD) product development, scientific research, and education in\u00a0Mexico<\/span>.<\/p>\n

“We appreciate the outpouring of support that we received at the opening of the first HempMeds\u00ae\u00a0Mexico<\/span>\u00a0office in\u00a0Monterrey, Mexico<\/span>, which reflects a growing demand for the Company’s zero-Tetrahidrocannabidiol (THC)\u00a0Real Scientific Hemp Oil-X\u2122 (RSHO-X\u2122<\/a>),” said Medical Marijuana, Inc. CEO Dr.\u00a0Stuart Titus<\/span>. “The extensive coverage that we received from both local and international media is a testament to the worldwide interest in cannabis reform happening in\u00a0Mexico<\/span>, and the efforts of HempMeds\u00ae\u00a0Mexico<\/span>\u00a0to provide products for this rapidly expanding CBD hemp oil market.”<\/p>\n

Coverage from the event included:<\/p>\n